FAM111B enhances proliferation of KRAS-driven lung adenocarcinoma by degrading p16
Open Access
- 1 July 2020
- journal article
- research article
- Published by Wiley in Cancer Science
- Vol. 111 (7), 2635-2646
- https://doi.org/10.1111/cas.14483
Abstract
Lung cancer is a common type of cancer that represents a health problem worldwide; lung adenocarcinoma (LUAD) is a major subtype of lung cancer. Although several treatments for LUAD have been developed, the mortality rate remains high because of uncontrollable progression. Further biological and clinicopathological studies are therefore needed. Here, we investigated the role of family with sequence similarity 111 member B (FAM111B), which is highly expressed in papillary-predominant LUAD; however, its role in cancer is unclear. An immunohistochemical analysis confirmed that papillary-predominant adenocarcinomas exhibited higher expression of FAM111B, compared with lepidic-predominant adenocarcinomas. Additionally, FAM111B expression was significantly correlated with clinical progression. In vitro functional analyses using FAM111B-knockout cells demonstrated that FAM111B plays an important role in proliferation and cell cycle progression of KRAS-driven LUAD under serum-starvation conditions. Furthermore, FAM111B regulated cyclin D1-CDK4-dependent cell cycle progression by degradation of p16. In summary, we revealed the clinical importance of FAM111B in human tumor tissues, as well as its function as a degradative enzyme. Therefore, FAM111B has potential as a clinicopathological prognostic marker for LUAD.Funding Information
- Japan Society for the Promotion of Science London (A19H034520, T17K195550, T18K150780, T18K150790, T19K165570, T19K165850)
This publication has 16 references indexed in Scilit:
- CUGC for hereditary fibrosing poikiloderma with tendon contractures, myopathy, and pulmonary fibrosis (POIKTMP)European Journal of Human Genetics, 2015
- Cyclin alterations in diverse cancers: outcome and co-amplification networkOncotarget, 2014
- Genetic Screens in Human Cells Using the CRISPR-Cas9 SystemScience, 2014
- Mutations in FAM111B Cause Hereditary Fibrosing Poikiloderma with Tendon Contracture, Myopathy, and Pulmonary FibrosisAmerican Journal of Human Genetics, 2013
- Prognostic value of the IASLC/ATS/ERS classification in stage I lung adenocarcinoma patients—Based on a hospital study in ChinaEuropean Journal of Surgical Oncology, 2013
- The Novel Histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society Classification System of Lung Adenocarcinoma Is a Stage-Independent Predictor of SurvivalJournal of Clinical Oncology, 2012
- A Grading System of Lung Adenocarcinomas Based on Histologic Pattern is Predictive of Disease Recurrence in Stage I TumorsThe American Journal of Surgical Pathology, 2010
- Cancer Statistics, 2008CA: A Cancer Journal for Clinicians, 2008
- True Papillary Carcinoma of the LungThe American Journal of Surgical Pathology, 1997
- Mutational Activation of the K-rasOncogeneThe New England Journal of Medicine, 1987